Výsledky vyhledávání - "Milena Pintimalli"

Cytarabine assures a high concentration of circulating CD34+ cells during haematopoietic stem cells mobilization in lymphoma patients

Autor: Ivo Gentilini, Lucia Canzian, Massimo Daves, Ahmad Al-Khaffaf, Ugo Salvadori, Milena Pintimalli, Roberto Melotti

Publikováno v: La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine. 13:173-179

Mobilization of haematopoietic stem cells for autologous transplantation in lymphoma patients currently lacks optimal and universally accepted protocol guidelines. Available mobilization procedures use either cytokines alone, predominantly granulocyt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9ed42686b8d5d8bbf37aefe1a5f4cab9
https://doi.org/10.1007/s13631-017-0165-7

Zobrazit plný text záznamu

Frontline High Dose Sequential Chemotherapy with Rituximab (R-HDS) and Autologous Stem Cell Transplantation Induces High Rates of Complete Response and Prolongs Survival in Mantle Cell Lymphoma (MCL)

Autor: Andrea Rossi, Corrado Tarella, Tiziano Barbui, Manuela Zanni, Fabio Benedetti, Mario Boccadoro, Milena Pintimalli, Angelo Andreini, Michele Magni, Atto Billio, Sergio Cortelazzo, Maddalena Marchesi, Michael Mian, Alessandro Rambaldi, Alessandro M. Gianni, Giovanni Pizzolo

Publikováno v: Blood. 108:3045-3045

We showed recently that the dismal outcome of MCL might be improved in 28 young patients (pts) (60 years with an age-adapted R-HDS. We report the outcome of 54 young pts (group 1), including the first 28 cases and that of 19 elderly pts (group 2). Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ec125766575c8bf4f4cf3f10ffebac9
https://doi.org/10.1182/blood.v108.11.3045.3045

Zobrazit plný text záznamu

Favorable Influence of Rituximab with High Dose Sequential Chemotherapy (R-HDS) Programs and Autologous Stem Cell Transplantation (ASCT) in Salvage Treatment for Patients with Refractory or Relapsed B-Cell Non-Hodgkin’s Lymphoma

Autor: Atto Billio, Tiziano Barbui, Sergio Cortelazzo, Giovanni Pizzolo, Andrea Rossi, Marco Sorio, Fabio Benedetti, Alessandro Rambaldi, Michael Mian, Milena Pintimalli

Publikováno v: Blood. 108:2744-2744

High-dose sequential (HDS) chemotherapy followed by ASCT proved to be an effective salvage therapy for patients (pts) with refractory or recurrent non-Hodgkin’s lymphoma (NHL) (Cortelazzo et al Br J Haematol, 2001). The addition of Rituximab to HDS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fce9ec638b1f9ce9fda632942994154b
https://doi.org/10.1182/blood.v108.11.2744.2744

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání